Alec has collaborated extensively with global life sciences innovators, leading strategic engagements across product and organizational life cycles. While Alec has tackled a diverse range of business problems, areas of particular focus include platform growth strategy, corporate strategy (asset and therapeutic area), and business development, both for biopharma and investors. In that context, Alec has deep experience across major therapeutic areas, with recent emphasis in neurology, oncology/hematology, orphan diseases, and immunology. When partnering with clients, Alec strives to bridge technical/clinical perspectives to clear business implications for organizations, and articulate realistic paths forward.
Alec has 6+ years of experience in life sciences consulting and research. Alec holds an MBA from MIT Sloan and B.A.s in Neuroscience and Economics from Dartmouth College.
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
David Gilman
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Steve Rubman
Debbi Amanti Belanger
Kim Goh
Slater Hurst
Dave Konciak
Charles Mathews
Mike Rizzo
Mike Roy
Ryan Tubman
Beko Binder
Jonny Betts
Dean Griffiths
Maneesh Gujrati
Austin Hubbert
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian